Spectrum Pharmaceuticals (SPPI) Stock Price, News & Analysis

Company Overview

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products. It offers ROLVEDON(Eflapegrastim), a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia. The company develops Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and license agreement with Therapyx, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Boston, Massachusetts.

Key Stats

• Today's Range: $1.03 to $1.03
• 50-Day Range: $0.94 to $1.03
• 52-Week Range: $0.32 to $1.57
• Volume: N/A
• Average Volume: 1.93 million shs
• Market Capitalization: $211.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SPPI Stock Analysis - Frequently Asked Questions

How were Spectrum Pharmaceuticals' earnings last quarter?

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) issued its quarterly earnings data on Wednesday, November, 10th. The biotechnology company reported ($0.21) EPS for the quarter, topping analysts' consensus estimates of ($0.28) by $0.07.

What other stocks do shareholders of Spectrum Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Spectrum Pharmaceuticals investors own include Enovix (ENVX), Rambus (RMBS), COMPASS Pathways (CMPS), Globant (GLOB), Toast (TOST), Ginkgo Bioworks (DNA) and NOVONIX (NVNXF).

Company Calendar

• Last Earnings: 11/10/2021
• Today: 12/27/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: Biotechnology
• Current Symbol: NASDAQ:SPPI
• CUSIP: 84763A10
• CIK: 831547
• Web: www.sppirx.com
• Phone: (617) 586-3900
• Fax: 702-260-7405
• Employees: 86
• Year Founded: 2002

Profitability

• EPS (Most Recent Fiscal Year): ($0.36)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-75,400,000.00
• Net Margins: N/A
• Pretax Margin: -263.04%
• Return on Equity: -218.44%
• Return on Assets: -66.16%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.71
• Quick Ratio: 2.38

Sales & Book Value

• Annual Sales: $10.11 million
• Price / Sales: 20.91
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.15 per share
• Price / Book: 6.87

Miscellaneous

• Outstanding Shares: 205,250,000
• Free Float: 199,704,000
• Market Cap: $211.41 million
• Optionable: Optionable
• Beta: 2.15